This company listing is no longer active

Mr. Patrick Brenske has been Chief Executive Officer of MPH Health Care AG (formerly known as MPH Mittelständische Pharma Holding AG) since January 23, 2009 and has been its Member of Management Board sinc...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Sabine Meck	Deputy Chairwoman of the Supervisory Board	16.4yrs	geen gegevens	geen gegevens
Andrea Grosse	Chairwoman of the Supervisory Board	11yrs	geen gegevens	geen gegevens
Uwe Zimdars	Member of Supervisory Board	3.2yrs	geen gegevens	geen gegevens

11.0yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van HAEK zijn ervaren en ervaren (gemiddelde ambtstermijn van 11 jaar).

This company listing is no longer active

HAEMATO Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

HAEMATO AG, Annual General Meeting, Jul 16, 2024

HAEMATO AG Appoints Attila Strauss to the Executive Board of the Company with Effect from April 1, 2022

HAEMATO AG Announces Board Changes

HAEMATO AG, Annual General Meeting, Jul 13, 2021

HAEMATO AG Appoints Patrick Brenske to the Management Board

Recent updates

HAEMATO AG, Annual General Meeting, Jul 16, 2024

What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?

Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk

Consensus EPS estimates increase by 18%

The Returns At HAEMATO (ETR:HAEK) Aren't Growing

New minor risk - Earnings quality

New major risk - Revenue and earnings growth

HAEMATO AG Confirms Guidance for the 2023 Financial Year

Haemato Ag Provides Earnings Guidance for the Year 2023

Upcoming dividend of €1.20 per share at 5.2% yield

Consensus EPS estimates increase by 19%

HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

Consensus EPS estimates increase by 22%

HAEMATO AG to Report Q3, 2023 Results on Nov 16, 2023

HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

Consensus forecasts updated

Price target decreased to €33.85

First half 2022 earnings released: EPS: €0.17 (vs €1.35 in 1H 2021)

HAEMATO AG Reaffirms its Earnings Guidance for the full year 2022

Upcoming dividend of €1.10 per share

HAEMATO AG Provides Earnings Guidance for the Year 2022

The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business

Price target decreased to €41.17

Full year 2021 earnings: Revenues miss analyst expectations

HAEMATO AG Provides Sales Guidance for the Year 2022

HAEMATO AG Appoints Attila Strauss to the Executive Board of the Company with Effect from April 1, 2022

HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns

HAEMATO AG Provides Earnings Guidance for the Year 2021

Upcoming dividend of €1.00 per share

HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around

Full year 2020 earnings released: €2.02 loss per share (vs €0.51 loss in FY 2019)

HAEMATO AG Proposes Dividend Payment

Price target decreased to €38.00

We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate

CEO, CFO & Member of the Executive Board Daniel Kracht has left the company

What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?

New 90-day low: €19.80

HAEMATO AG Announces Board Changes

Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)

HAEMATO AG, Annual General Meeting, Jul 13, 2021

New 90-day high: €24.00

Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?

Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years

HAEMATO AG Appoints Patrick Brenske to the Management Board

New 90-day low: €19.00

New 90-day low: €21.00

New 90-day low: €23.10

M1 Kliniken AG (XTRA:M12) completed the acquisition of 48.16% stake in HAEMATO AG (XTRA:HAE) from MPH Health Care AG (XTRA:93M).

Price target lowered to €37.50

CEO

Tenure

Bestuursleden

Gemiddelde duur